ペプチド合成市場：製品タイプ、技術、用途、エンドユーザー別-2025-2030年世界予測

ペプチド合成市場の2024年の市場規模は7億6,901万米ドルで、2025年には8億2,684万米ドルに成長し、CAGRは7.84％、2030年には12億984万米ドルに達すると予測されています。

ペプチド合成は現代の科学技術において重要な分野として浮上しており、医薬品、診断、研究の進歩のバックボーンとしての役割を果たしています。近年、高精度と効率に対する要求の高まりが技術革新の起爆剤となり、伝統的な手法から最先端の自動化システムへと方法論を押し上げています。本サマリーでは、この分野を再構築しつつある現在の動向、技術的ブレークスルー、戦略的市場セグメントについて詳しく解説します。

進化する科学的課題と合理化された生産プロセスの必要性が相まって、企業や研究機関はより洗練されたアプローチを採用するようになりました。新しい合成技術が開発され、既存のプロセスが改良されるにつれて、ペプチド生産の全体的なエコシステムは拡大し続けています。この拡大は、初期段階の探索研究から複雑な治療用ペプチドの生産まで、幅広い応用を支えています。さらに、自動化と統合された品質管理への最近の投資により、精度とスケーラビリティが融合する枠組みが確立され、再現性とコスト効率の向上が可能になりました。

新たな情勢は、学界、業界、技術プロバイダー間の協力によって特徴付けられ、それぞれが業界を前進させる上で重要な役割を果たしています。こうした力学を理解することは、規制上の課題、技術統合、世界なサプライチェーンの複雑さを乗り越えなければならない利害関係者にとって不可欠です。急速な技術革新が絶えずこの業界を再構築している環境では、進化する市場動向に対する明確な視点を維持することは、戦略的な決断というだけでなく、ますますダイナミックになる市場で競争力を維持するために必要不可欠となります。

ペプチド合成の情勢を形成する変革的変化

過去10年間で、自動化の強化、品質管理技術の向上、分野横断的な協力関係の強化などが主な要因となり、変革的なシフトがペプチド合成の状況を再定義してきました。技術の進歩は、多くの従来の方法に取って代わる、精密で、迅速で、コスト効率の良い合成プロセスを可能にし、革新が進歩の礎となる環境を育んできました。

特筆すべき変化のひとつは、洗練されたロボット・プラットフォームと、生産時間を大幅に短縮しながら人的ミスを最小限に抑えるコンピューター支援プロセスの統合です。これらの進歩は、ペプチド合成の精度を向上させただけでなく、医薬品やバイオテクノロジー製造の大量生産の要求に応えるためのスケールアップ生産も可能にしました。その結果、産業界はより高いレベルの一貫性と信頼性を達成できるようになり、治療用ペプチドやワクチン候補の開発加速に直接貢献しています。

さらに、液相合成法と固相合成法の両方を組み合わせたハイブリッド技術の利用が増えたことで、柔軟性と効率が向上しました。この進化は、受容体結合研究から複雑な創薬プロセスまで、ペプチド開発のあらゆる段階を最適化するという業界全体のコミットメントを反映しています。さらに、進化する規制の枠組みは現在、強固な品質保証プロトコールとトレーサビリティを実証するプラットフォームを支持しており、技術改革に新たな推進力を加えています。こうした変革のシフトは、コスト削減や持続可能性向上の機会を生み出すだけでなく、次世代研究イノベーションへの道を開き、最終的には市場リーダーや利害関係者の戦略的選択に影響を与えます。

ペプチド合成市場の主なセグメンテーション洞察

ペプチド合成市場は、複数の分析レイヤーを掘り下げる多面的なセグメンテーション戦略を特徴としています。製品タイプのセグメンテーションを検討する場合、市場は装置、試薬、消耗品、サービスにわたって包括的に調査されます。機器分析では、クロマトグラフィー機器、凍結乾燥機、ペプチド合成機に焦点を当てることで、さらに詳細な分析を行っており、それぞれが合成プロセスの効率性と信頼性において極めて重要な役割を果たしています。並行して、試薬と消耗品は、アミノ酸、カップリング試薬、染料、蛍光標識試薬のような必須成分と、合成プロセスのバックボーンとして機能する様々な樹脂のレンズを通して精査されます。

さらに、技術に基づくセグメンテーションは、市場理解の重要な側面を反映しています。ハイブリッド技術、液相ペプチド合成、固相ペプチド合成などのアプローチを評価することで、この分野における技術革新のペースと適応性を定義する技術動向を明らかにしています。この技術的セグメンテーションは、進化するプロセスが市場の成長と業務効率にどのような影響を及ぼしているかについての貴重な洞察を提供します。

ハードウェアと技術コンポーネントにとどまらず、市場のアプリケーションセグメンテーションは、診断、調査、治療など、多様な用途を示します。これらの用途は、それぞれ異なる需要パターンとイノベーション戦略を推進します。さらに、エンドユーザーのセグメンテーションは、主要ユーザーに基づいて市場を分類することで、別の側面を提供します。これには、基礎科学を推進する学術研究機関、診断の進歩に携わる臨床検査機関、共同プロジェクトを促進する受託研究機関、製品開発と商業化のためにペプチド合成を活用する製薬・バイオテクノロジー企業などが含まれます。これらのセグメンテーションの洞察から、市場は多様でダイナミックであり、イノベーション、投資、成長のための複数の手段を提供していることが明らかになりました。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • バイオ医薬品およびペプチドベースの治療薬の需要増加
    • バイオ医薬品調査に対する政府のインセンティブと支援的な規制枠組み
    • 世界中でバイオテクノロジーと製薬分野の拡大
  • 抑制要因
    • 原材料費が高く、合成試薬も高価
  • 機会
    • 計算モデリングとペプチド設計の進歩が革新的な治療開発を推進
    • 学術界と産業界における研究開発活動の拡大
  • 課題
    • 厳格な規制枠組みとコンプライアンスの問題
• 市場セグメンテーション分析
  • 製品タイプ：生体活性維持のための凍結乾燥装置の重要性の高まり
  • 応用：調査分野におけるペプチド合成の応用拡大
  • 技術：ペプチドの収量と純度が高いため、ハイブリスと組み換え技術の潜在能力が高まっている
  • エンドユーザー：製薬会社およびバイオ製薬会社による新薬発見のためのペプチド合成の利用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 ペプチド合成市場：製品タイプ別

• 装置
  • クロマトグラフィー装置
  • 凍結乾燥装置
  • ペプチド合成装置
• 試薬と消耗品
  • アミノ酸
  • カップリング試薬
  • 染料および蛍光標識試薬
  • 樹脂
• サービス

第7章 ペプチド合成市場：技術別

• ハイブリッド技術
• 液相ペプチド合成
• 固相ペプチド合成

第8章 ペプチド合成市場：用途別

• 診断
• 調査
• 治療薬

第9章 ペプチド合成市場：エンドユーザー別

• 学術調査
• 臨床検査室
• 契約調査機関
• 製薬・バイオテクノロジー企業

第10章 南北アメリカのペプチド合成市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のペプチド合成市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのペプチド合成市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 2B Scientific Limited
• AAPPTec
• ABclonal, Inc.
• Advanced ChemTech
• Almac Group Limited
• AmbioPharm Inc.
• AnaSpec Inc.
• Bachem AG
• Biocon Limited
• BioDuro LLC
• Biosynth Ltd.
• Biotage
• CEM Corporation
• CPC Scientific Inc.
• Creative Diagnostics
• Creative Peptides
• CSBio
• Enamine Ltd.
• GenScript Biotech Corporation
• Gyros Protein Technologies AB
• Hybio Pharmaceutical Co., Ltd.
• JPT Peptide Technologies GmbH by TheraCode GmbH
• Kaneka Corporation
• LifeTein LLC
• Merck KGaA
• New England BioGroup, LLC
• Novo Nordisk A/S
• PolyPeptide Group AG
• Thermo Fisher Scientific Inc.
• USV Private Limited

LIST OF FIGURES

• FIGURE 1. PEPTIDE SYNTHESIS MARKET MULTI-CURRENCY
• FIGURE 2. PEPTIDE SYNTHESIS MARKET MULTI-LANGUAGE
• FIGURE 3. PEPTIDE SYNTHESIS MARKET RESEARCH PROCESS
• FIGURE 4. PEPTIDE SYNTHESIS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. PEPTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PEPTIDE SYNTHESIS MARKET DYNAMICS
• TABLE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUPLING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DYES & FLUROSCENT LABELING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY HYBRID TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LIQUID PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLID PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 54. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 55. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 86. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 87. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 92. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 93. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 194. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 195. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 196. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 218. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 219. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 220. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 221. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 224. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 225. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 226. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 227. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 283. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 284. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024

The Peptide Synthesis Market was valued at USD 769.01 million in 2024 and is projected to grow to USD 826.84 million in 2025, with a CAGR of 7.84%, reaching USD 1,209.84 million by 2030.

Peptide synthesis has emerged as a critical area in modern science and technology, serving as a backbone for advances in pharmaceuticals, diagnostics, and research. In recent years, increasing demands for high precision and efficiency have catalyzed innovation, driving methodologies from traditional practices to state-of-the-art automated systems. This summary provides an in-depth look at current trends, technological breakthroughs, and strategic market segments that are reshaping the field.

A combination of evolving scientific challenges and the need for streamlined production processes has led companies and research institutions to adopt more sophisticated approaches. As new synthesis techniques are developed and existing processes refined, the overall ecosystem for peptide production continues to expand. This expansion supports a wide variety of applications ranging from early-stage discovery research to the production of complex therapeutic peptides. Furthermore, recent investments in automation and integrated quality control have established a framework where precision meets scalability, enabling enhanced reproducibility and cost efficiency.

The emerging landscape is characterized by collaboration between academia, industry, and technology providers, each playing a crucial role in driving the industry forward. Understanding these dynamics is essential for stakeholders who must navigate regulatory challenges, technological integration, and global supply chain complexities. In an environment where rapid innovation continuously reshapes the sector, maintaining a clear perspective on evolving market trends becomes not only a strategic decision but a necessity for staying competitive in an increasingly dynamic space.

Transformative Shifts Reshaping the Peptide Synthesis Landscape

Over the past decade, transformative shifts have redefined the landscape of peptide synthesis, driven primarily by enhanced automation, improved quality control techniques, and greater cross-disciplinary collaboration. Advances in technology have allowed for precise, rapid, and cost-effective synthesis processes that have replaced many conventional methods, fostering an environment in which innovation is the cornerstone of progress.

One notable shift has been the integration of sophisticated robotic platforms and computer-assisted processes that minimize human error while drastically reducing production time. These advancements have not only improved the accuracy of peptide synthesis but have also enabled scaled-up production to meet the demands of high-volume pharmaceutical and biotech manufacturing. As a result, industries are now capable of achieving higher levels of consistency and reliability, which directly contributes to the accelerated development of therapeutic peptides and vaccine candidates.

Additionally, the increasing use of hybrid technologies that combine both liquid and solid-phase synthesis methods has provided greater flexibility and efficiency. This evolution reflects an industry-wide commitment to optimizing every stage of peptide development, from receptor binding studies to complex drug discovery processes. Furthermore, evolving regulatory frameworks are now favoring platforms that demonstrate robust quality assurance protocols and traceability, adding another layer of impetus to technological reforms. These transformative shifts not only create opportunities for cost savings and improved sustainability but also pave the way for next-generation research innovations, ultimately influencing the strategic choices of market leaders and stakeholders alike.

Key Segmentation Insights in the Peptide Synthesis Market

The peptide synthesis market is characterized by a multifaceted segmentation strategy that delves into several layers of analysis. When examining product type segmentation, the market is comprehensively studied across equipment, reagents and consumables, as well as services. Equipment analysis is further detailed by focusing on chromatography equipment, lyophilizers, and peptide synthesizers, each playing a pivotal role in the efficiency and reliability of synthesis processes. In parallel, reagents and consumables are scrutinized through the lens of essential components like amino acids, coupling reagents, dyes and fluorescent labeling reagents, along with various resins that serve as the backbone of the synthetic process.

Furthermore, segmentation based on technology reflects a critical aspect of market understanding. By evaluating approaches such as hybrid technology, liquid phase peptide synthesis, and solid phase peptide synthesis, the analysis uncovers technological trends that define the innovation pace and adaptability within the sector. This technological segmentation offers valuable insights into how evolving processes are influencing market growth and operational efficiency.

Beyond hardware and technological components, the application segmentation of the market illustrates a diverse array of uses including diagnosis, research, and therapeutics. Each of these applications drives distinct demand patterns and innovation strategies. Additionally, end-user segmentation provides another dimension by categorizing the market based on primary users. This includes academic research entities that drive foundational science, clinical laboratories engaged indiagnostic advancements, contract research organizations that facilitate collaborative projects, and pharmaceutical and biotech companies that leverage peptide synthesis for product development and commercialization. Together, these segmentation insights reveal a market that is as diverse as it is dynamic, offering multiple avenues for innovation, investment, and growth.

Based on Product Type, market is studied across Equipment, Reagents & Consumables, and Services. The Equipment is further studied across Chromatography Equipment, Lyophilizers, and Peptide Synthesizers. The Reagents & Consumables is further studied across Amino Acids, Coupling Reagents, Dyes & Fluroscent Labeling Reagents, and Resins.

Based on Technology, market is studied across Hybrid Technology, Liquid Phase Peptide Synthesis, and Solid Phase Peptide Synthesis.

Based on Application, market is studied across Diagnosis, Research, and Therapeutics.

Based on End-User, market is studied across Academic Research, Clinical Laboratories, Contract Research Organizations, and Pharmaceutical & Biotech Companies.

Regional Insights Driving Market Dynamics

The global footprint of peptide synthesis is expansive, with regional distinctions that reveal unique market dynamics and localized growth opportunities. In regions such as the Americas, advanced research infrastructure and the robust presence of pharmaceutical giants have established a competitive marketplace, fostering rapid adoption of innovative synthesis technologies. Dynamic regulatory frameworks and a strong emphasis on research and development contribute significantly to the progressive landscape in this part of the world.

In Europe, the Middle East, and Africa, a combination of historical expertise in fine chemicals and growing investments in biotechnology is catalyzing transformative changes. The region is witnessing a steady expansion of collaborative projects, bolstered by governmental support for medical research and technology integration. Regulatory harmonization across various countries has streamlined processes, facilitating wider adoption of advanced peptide synthesis techniques.

Asia-Pacific represents another critical driver of market expansion, characterized by its accelerating pace of industrialization and a burgeoning scientific community. With increasing investments in research and state-of-the-art laboratories, this region is rapidly becoming a center for both technological advancements and large-scale production. The confluence of economic growth, favorable investment climates, and an expanding base of skilled professionals has set the stage for significant breakthroughs in peptide synthesis. These regional insights highlight distinct growth patterns and innovation drivers, underscoring the importance for market stakeholders to adopt region-specific strategies to capitalize on emerging opportunities.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights from Leading Industry Players

The competitive landscape in peptide synthesis is marked by the active participation of leading industry players, each contributing unique expertise and driving the overall momentum of the sector. Companies such as 2B Scientific Limited, AAPPTec, ABclonal, Inc., and Advanced ChemTech have steadily gained recognition for their contributions to groundbreaking research and innovative product development. These organizations leverage state-of-the-art technologies to optimize synthesis processes and deliver high-quality outcomes.

Other notable contributors include Almac Group Limited, AmbioPharm Inc., AnaSpec Inc., and Bachem AG, which have established themselves as trusted names in the field. Their commitment to integrating advanced methodologies with robust quality control mechanisms ensures that the supply chain remains resilient and adaptive to change. Entities such as Biocon Limited, BioDuro LLC, and Biosynth Ltd. have further enhanced the competitive landscape by focusing on specialized research and offering tailored solutions in peptide synthesis.

In addition, prominent names like Biotage, CEM Corporation, CPC Scientific Inc., and Creative Diagnostics have built a reputation on the consistent reliability of their equipment and reagents. Companies such as Creative Peptides, CSBio, and Enamine Ltd. are constantly pushing the boundaries of research innovation, interfacing technology with application-specific insights to drive market differentiation. GenScript Biotech Corporation, Gyros Protein Technologies AB, Hybio Pharmaceutical Co., Ltd., and JPT Peptide Technologies GmbH by TheraCode GmbH demonstrate a deep commitment to nurturing scientific excellence, while Kaneka Corporation, LifeTein LLC, Merck KGaA, and New England BioGroup, LLC influence market trends with their forward-thinking strategies. Additionally, Novo Nordisk A/S, PolyPeptide Group AG, Thermo Fisher Scientific Inc., and USV Private Limited round out a competitive field that continues to set benchmarks in quality, efficiency, and innovation in peptide synthesis. Collectively, these companies create a rich tapestry of expertise that drives both incremental improvements and disruptive changes across the industry.

The report delves into recent significant developments in the Peptide Synthesis Market, highlighting leading vendors and their innovative profiles. These include 2B Scientific Limited, AAPPTec, ABclonal, Inc., Advanced ChemTech, Almac Group Limited, AmbioPharm Inc., AnaSpec Inc., Bachem AG, Biocon Limited, BioDuro LLC, Biosynth Ltd., Biotage, CEM Corporation, CPC Scientific Inc., Creative Diagnostics, Creative Peptides, CSBio, Enamine Ltd., GenScript Biotech Corporation, Gyros Protein Technologies AB, Hybio Pharmaceutical Co., Ltd., JPT Peptide Technologies GmbH by TheraCode GmbH, Kaneka Corporation, LifeTein LLC, Merck KGaA, New England BioGroup, LLC, Novo Nordisk A/S, PolyPeptide Group AG, Thermo Fisher Scientific Inc., and USV Private Limited. Actionable Recommendations for Forward-Thinking Industry Leaders

Industry leaders must now consider a composite of strategic approaches in order to not only keep pace with ongoing innovation but to actively shape future trends in peptide synthesis. First and foremost, investing in advanced automation and integrating hybrid synthesis techniques can yield significant benefits. Companies that allocate resources toward cutting-edge machinery and data-driven quality control are poised to improve operational efficiency and reduce error margins. Decision-makers should also consider establishing robust partnerships across research institutions, technology providers, and regulatory bodies. Such collaborations facilitate the swift interchange of knowledge and best practices, allowing businesses to remain agile in the face of technological disruption.

In addition to technological investments, there is a critical need to adapt end-to-end processes to incorporate sustainable practices. As environmental concerns take center stage globally, adopting eco-friendly reagents, energy-efficient equipment, and waste reduction protocols will not only drive cost savings but also bolster a company's reputation in the market. Leaders should also focus on diversifying their product portfolios by exploring niche applications in diagnosis, research, and therapeutics. This deliberate diversification can serve as a buffer against market volatility, ensuring stable revenue streams under varying economic conditions.

With the rapidly evolving regulatory landscape, it is essential to stay ahead by investing in compliance and training programs. This proactive approach will help mitigate risks associated with new guidelines while reinforcing the reliability of synthesis outputs. By harnessing data analytics and embracing digital transformation, industry leaders can unlock actionable insights that inform long-term strategic planning. These recommendations are designed to empower decision-makers to not only respond to current challenges but also to set a robust foundation for sustainable growth and innovation in the peptide synthesis market.

Conclusion: Synthesis of Insights and Future Outlook

The evolving landscape of peptide synthesis presents numerous opportunities marked by technological innovation, regional dynamics, and competitive excellence. The insights drawn from product type and technology segmentations, coupled with a thorough understanding of market applications and end-user profiles, create a roadmap for strategic investment and operational enhancement. As regional markets mature and industry leaders consolidate their expertise, the path ahead is clear: adaptability and proactive innovation are key to thriving in this competitive arena.

In summary, the comprehensive analysis presented herein underscores the importance of marrying technology with strategy in a market that is both dynamic and transformative. This synthesis not only encapsulates current trends but also offers a vision for future growth and sustained success in the peptide synthesis market.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for biopharmaceuticals and peptide-based therapeutics
    • 5.1.1.2. Government incentives and supportive regulatory frameworks for biopharma research
    • 5.1.1.3. Expansion of biotechnology and pharmaceutical sectors across globe
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of raw materials and expensive synthesis reagents
  • 5.1.3. Opportunities
    • 5.1.3.1. Advances in computational modeling and peptide design driving innovative therapeutic developments
    • 5.1.3.2. Expansion of research and development activities both in academia and industry
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory frameworks and compliance issues
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Rising significance of lyophilizers for maintaining bioactivity
  • 5.2.2. Application: Expanding application of peptide synthesis in research sector
  • 5.2.3. Technology: Rising potential of hybris & recombinant technology as it offers high peptide yield and purity
  • 5.2.4. End-User: Expanding usage of peptide synthesis by pharmaceutical & biopharmaceutical companies for drug discovery
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Peptide Synthesis Market, by Product Type

• 6.1. Introduction
• 6.2. Equipment
  • 6.2.1. Chromatography Equipment
  • 6.2.2. Lyophilizers
  • 6.2.3. Peptide Synthesizers
• 6.3. Reagents & Consumables
  • 6.3.1. Amino Acids
  • 6.3.2. Coupling Reagents
  • 6.3.3. Dyes & Fluroscent Labeling Reagents
  • 6.3.4. Resins
• 6.4. Services

7. Peptide Synthesis Market, by Technology

• 7.1. Introduction
• 7.2. Hybrid Technology
• 7.3. Liquid Phase Peptide Synthesis
• 7.4. Solid Phase Peptide Synthesis

8. Peptide Synthesis Market, by Application

• 8.1. Introduction
• 8.2. Diagnosis
• 8.3. Research
• 8.4. Therapeutics

9. Peptide Synthesis Market, by End-User

• 9.1. Introduction
• 9.2. Academic Research
• 9.3. Clinical Laboratories
• 9.4. Contract Research Organizations
• 9.5. Pharmaceutical & Biotech Companies

10. Americas Peptide Synthesis Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Peptide Synthesis Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Peptide Synthesis Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. BioDuro expands CRDMO capabilities with new automated solid-phase peptide synthesis scale-up facility in Shanghai
  • 13.3.2. PolyPeptide Group AG launches new large-scale SPPS facility in Braine-l'Alleud
  • 13.3.3. Cambrex unveils scalable and sustainable liquid-phase peptide synthesis technology
  • 13.3.4. Biosynth Extends Peptide Synthesis Offering With Pepceuticals Acquisition
  • 13.3.5. GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs
  • 13.3.6. Mesa Labs Acquires Belyntic's Peptide Purification Business
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 2B Scientific Limited
• 2. AAPPTec
• 3. ABclonal, Inc.
• 4. Advanced ChemTech
• 5. Almac Group Limited
• 6. AmbioPharm Inc.
• 7. AnaSpec Inc.
• 8. Bachem AG
• 9. Biocon Limited
• 10. BioDuro LLC
• 11. Biosynth Ltd.
• 12. Biotage
• 13. CEM Corporation
• 14. CPC Scientific Inc.
• 15. Creative Diagnostics
• 16. Creative Peptides
• 17. CSBio
• 18. Enamine Ltd.
• 19. GenScript Biotech Corporation
• 20. Gyros Protein Technologies AB
• 21. Hybio Pharmaceutical Co., Ltd.
• 22. JPT Peptide Technologies GmbH by TheraCode GmbH
• 23. Kaneka Corporation
• 24. LifeTein LLC
• 25. Merck KGaA
• 26. New England BioGroup, LLC
• 27. Novo Nordisk A/S
• 28. PolyPeptide Group AG
• 29. Thermo Fisher Scientific Inc.
• 30. USV Private Limited